Literature DB >> 26968772

(-)-Epicatechin improves insulin sensitivity in high fat diet-fed mice.

Eleonora Cremonini1, Ahmed Bettaieb2, Fawaz G Haj3, Cesar G Fraga4, Patricia I Oteiza5.   

Abstract

Obesity constitutes a major public health concern, being frequently associated with type 2 diabetes (T2D). Evidence from studies in humans and experimental animals suggest that consumption of the flavan-3-ol (-)-epicatechin (EC) and of EC-rich foods may improve insulin sensitivity. To further understand the potential benefits of dietary EC consumption on insulin resistance, this study investigated the capacity of EC supplementation to prevent high fat diet (HFD)-induced insulin resistance in mice. To assess the underlying mechanisms, the effects of HFD and EC consumption on the activation of the insulin cascade and of its negative modulators were evaluated. HFD consumption for 15 w caused obesity and insulin resistance in C57BL/6J mice as evidenced by high fasted and fed plasma glucose and insulin levels, and impaired ITT and GTT tests. This was associated with alterations in the activation of components of the insulin-triggered signaling cascade (insulin receptor, IRS1, ERK1/2, Akt) in adipose and liver tissues. EC supplementation prevented/ameliorated all these parameters. EC acted improving insulin sensitivity in the HFD-fed mice in part through a downregulation of the inhibitory molecules JNK, IKK, PKC and protein tyrosine phosphatase 1B (PTP1B). Thus, the above results suggest that consumption of EC-rich foods could constitute a dietary strategy to mitigate obesity-associated insulin resistance.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Diabetes; Epicatechin; Flavanol; Flavonoids; High fat diet; Insulin resistance; Obesity

Mesh:

Substances:

Year:  2016        PMID: 26968772      PMCID: PMC5523407          DOI: 10.1016/j.abb.2016.03.006

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  41 in total

Review 1.  Obesity and the regulation of energy balance.

Authors:  B M Spiegelman; J S Flier
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies.

Authors:  Mark G Shrime; Scott R Bauer; Anna C McDonald; Nubaha H Chowdhury; Cordelia E M Coltart; Eric L Ding
Journal:  J Nutr       Date:  2011-09-28       Impact factor: 4.798

3.  Food consumption, nutrient intake and the risk of having metabolic syndrome: the DR's EXTRA Study.

Authors:  R Kouki; U Schwab; M Hassinen; P Komulainen; H Heikkilä; T A Lakka; R Rauramaa
Journal:  Eur J Clin Nutr       Date:  2010-12-01       Impact factor: 4.016

4.  Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome.

Authors:  Ahmad Esmaillzadeh; Masoud Kimiagar; Yadollah Mehrabi; Leila Azadbakht; Frank B Hu; Walter C Willett
Journal:  Am J Clin Nutr       Date:  2006-12       Impact factor: 7.045

5.  A central role for JNK in obesity and insulin resistance.

Authors:  Jiro Hirosumi; Gürol Tuncman; Lufen Chang; Cem Z Görgün; K Teoman Uysal; Kazuhisa Maeda; Michael Karin; Gökhan S Hotamisligil
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

6.  Effects of (-)-epicatechin on a diet-induced rat model of cardiometabolic risk factors.

Authors:  Gabriel Gutiérrez-Salmeán; Pilar Ortiz-Vilchis; Claudia Maria Vacaseydel; Leticia Garduño-Siciliano; German Chamorro-Cevallos; Eduardo Meaney; Santiago Villafaña; Francisco Villarreal; Guillermo Ceballos; Israel Ramírez-Sánchez
Journal:  Eur J Pharmacol       Date:  2014-01-31       Impact factor: 4.432

7.  Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate.

Authors:  Davide Grassi; Giovambattista Desideri; Stefano Necozione; Cristina Lippi; Raffaele Casale; Giuliana Properzi; Jeffrey B Blumberg; Claudio Ferri
Journal:  J Nutr       Date:  2008-09       Impact factor: 4.798

8.  Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial.

Authors:  Peter J Curtis; Mike Sampson; John Potter; Ketan Dhatariya; Paul A Kroon; Aedín Cassidy
Journal:  Diabetes Care       Date:  2012-01-16       Impact factor: 19.112

9.  Flavonoid intake in European adults (18 to 64 years).

Authors:  Anna Vogiatzoglou; Angela A Mulligan; Marleen A H Lentjes; Robert N Luben; Jeremy P E Spencer; Hagen Schroeter; Kay-Tee Khaw; Gunter G C Kuhnle
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

10.  (-)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice.

Authors:  Chun-Ching Shih; Jin-Bin Wu; Jia-Ying Jian; Cheng-Hsiu Lin; Hui-Ya Ho
Journal:  Int J Mol Sci       Date:  2015-10-20       Impact factor: 5.923

View more
  20 in total

1.  A pilot study on clinical pharmacokinetics and preclinical pharmacodynamics of (+)-epicatechin on cardiometabolic endpoints.

Authors:  Aldo Moreno-Ulloa; Nayelli Nájera-García; Marcela Hernández; Israel Ramírez-Sánchez; Pam R Taub; Yongxuan Su; Ernesto Beltrán-Partida; Guillermo Ceballos; Sundeep Dugar; George Schreiner; Brookie M Best; Theodore P Ciaraldi; Robert R Henry; Francisco Villarreal
Journal:  Food Funct       Date:  2018-01-24       Impact factor: 5.396

2.  Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice.

Authors:  Ahmed Bettaieb; Eleonora Cremonini; Heeteak Kang; Jiye Kang; Fawaz G Haj; Patricia I Oteiza
Journal:  Int J Biochem Cell Biol       Date:  2016-08-31       Impact factor: 5.085

3.  Polyphenol intake and metabolic syndrome risk in European adolescents: the HELENA study.

Authors:  Ratih Wirapuspita Wisnuwardani; Stefaan De Henauw; Maria Forsner; Frédéric Gottrand; Inge Huybrechts; Viktoria Knaze; Mathilde Kersting; Cinzia Le Donne; Yannis Manios; Ascensión Marcos; Dénes Molnár; Joseph A Rothwell; Augustin Scalbert; Michael Sjöström; Kurt Widhalm; Luis A Moreno; Nathalie Michels
Journal:  Eur J Nutr       Date:  2019-03-22       Impact factor: 5.614

Review 4.  ( -)-Epicatechin and cardiometabolic risk factors: a focus on potential mechanisms of action.

Authors:  Ezequiel J Hid; Juana I Mosele; Paula D Prince; Cesar G Fraga; Monica Galleano
Journal:  Pflugers Arch       Date:  2021-11-23       Impact factor: 3.657

Review 5.  The potential role of phenolic compounds on modulating gut microbiota in obesity.

Authors:  Gow-Chin Yen; Hsin-Lin Cheng; Li-Yu Lin; Shiuan-Chih Chen; Chin-Lin Hsu
Journal:  J Food Drug Anal       Date:  2020-06-15       Impact factor: 6.157

6.  Epicatechin's cardiovascular protective effects are mediated via opioid receptors and nitric oxide.

Authors:  Kirsty MacRae; Kylie Connolly; Rebecca Vella; Andrew Fenning
Journal:  Eur J Nutr       Date:  2018-05-10       Impact factor: 5.614

Review 7.  Effects of Cocoa Antioxidants in Type 2 Diabetes Mellitus.

Authors:  Sonia Ramos; María Angeles Martín; Luis Goya
Journal:  Antioxidants (Basel)       Date:  2017-10-31

Review 8.  Therapeutic uses of epicatechin in diabetes and cancer.

Authors:  Layth Abdulmajeed Abdulkhaleq; Mohammed Abdulrazzaq Assi; Mohd Hezmee Mohd Noor; Rasedee Abdullah; Mohd Zamri Saad; Yun Hin Taufiq-Yap
Journal:  Vet World       Date:  2017-08-06

9.  (-)-Epicatechin and Anthocyanins Modulate GLP-1 Metabolism: Evidence from C57BL/6J Mice and GLUTag Cells.

Authors:  Eleonora Cremonini; Elena Daveri; Angela Mastaloudis; Patricia I Oteiza
Journal:  J Nutr       Date:  2021-06-01       Impact factor: 4.798

Review 10.  Regulation of Cytochrome c Oxidase by Natural Compounds Resveratrol, (-)-Epicatechin, and Betaine.

Authors:  Icksoo Lee
Journal:  Cells       Date:  2021-05-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.